Tabes Dorsalis epidemiology and demographics: Difference between revisions
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Tabes dorsalis}} | {{Tabes dorsalis}} | ||
{{CMG}} | {{CMG}} {{AE}};{{MMJ}} {{AA}}; {{NRM}} | ||
==Overview== | ==Overview== | ||
Tabes dorsalis is now very rare because [[syphilis]] is usually treated early in the disease. | Tabes dorsalis is now very rare because [[syphilis]] is usually treated early in the disease. In 2012, the [[incidence]] of [[syphilis]] was estimated to be 6 million cases worldwide. From year 2005 to 2014, the [[incidence]] of [[syphilis]] in the United States increased from 2.9 to 6.3 cases/100,000/year. The rate of reported cases increased by 15.1% between 2013 and 2014 in the United States. In 2012, the [[prevalence]] of syphilis was estimated to be approximately 18 million cases in men and women aged 15-29 worldwide. Among infected patients with [[Treponema pallidum]] only 3 to 5% develop [[neurosyphilis]] and only 5% of those individuals develop tabes dorsalis, 10–20 years later. | ||
In 2012, the [[incidence]] of [[syphilis]] was estimated to be 6 million cases worldwide. From year 2005 to 2014, the [[incidence]] of [[syphilis]] in the United States increased from 2.9 to 6.3 cases/100,000/year. The rate of reported cases increased by 15.1% between 2013 and 2014 in the United States. In 2012, the [[prevalence]] of syphilis was estimated to be approximately 18 million cases in men and women aged 15-29 worldwide. Among infected patients with [[Treponema pallidum]] only 3 to 5% develop [[neurosyphilis]] and only 5% of those individuals develop tabes dorsalis, 10–20 years later. | |||
== Epidemiology of syphilis and tabes dorsalis == | == Epidemiology of syphilis and tabes dorsalis == |
Revision as of 15:13, 28 February 2018
Tabes Dorsalis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Tabes Dorsalis epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Tabes Dorsalis epidemiology and demographics |
Risk calculators and risk factors for Tabes Dorsalis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: ;Mohamadmostafa Jahansouz M.D.[2] Aysha Anwar, M.B.B.S[3]; Nate Michalak, B.A.
Overview
Tabes dorsalis is now very rare because syphilis is usually treated early in the disease. In 2012, the incidence of syphilis was estimated to be 6 million cases worldwide. From year 2005 to 2014, the incidence of syphilis in the United States increased from 2.9 to 6.3 cases/100,000/year. The rate of reported cases increased by 15.1% between 2013 and 2014 in the United States. In 2012, the prevalence of syphilis was estimated to be approximately 18 million cases in men and women aged 15-29 worldwide. Among infected patients with Treponema pallidum only 3 to 5% develop neurosyphilis and only 5% of those individuals develop tabes dorsalis, 10–20 years later.
Epidemiology of syphilis and tabes dorsalis
Tabes dorsalis is now very rare because syphilis is usually treated early in the disease.
- In 2012, the incidence of syphilis was estimated to be 6 million cases worldwide.
- From year 2005 to 2014, the incidence of syphilis in the United States increased from 2.9 to 6.3 cases/100,000/year.
- The rate of reported cases increased by 15.1% between 2013 and 2014 in the United States.[1]
- Syphilis incidence increased in every region of the Untied States in 2014, with the highest rate in the West and lowest rate in the Midwest.
- In 2012, the prevalence of syphilis was estimated to be approximately 18 million cases in men and women aged 15-29 worldwide.[2]
- The incidence and prevalence of syphilis may be affected by age, gender, race, sexual behavior and geographical distribution.
- Among infected patients with Treponema pallidum only 3 to 5% develop neurosyphilis and only 5% of those individuals develop tabes dorsalis, 10–20 years later.[1][3][4][5][6][7][8]
References
- ↑ 1.0 1.1 https://www.cdc.gov/std/stats14/surv-2014-print.pdf Accessed on September 16, 2016
- ↑ Newman L, Rowley J, Vander Hoorn S, Wijesooriya NS, Unemo M, Low N; et al. (2015). "Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting". PLoS One. 10 (12): e0143304. doi:10.1371/journal.pone.0143304. PMC 4672879. PMID 26646541.
- ↑ Satterwhite CL, Torrone E, Meites E, Dunne EF, Mahajan R, Ocfemia MC; et al. (2013). "Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008". Sex Transm Dis. 40 (3): 187–93. doi:10.1097/OLQ.0b013e318286bb53. PMID 23403598.
- ↑ http://apps.who.int/iris/bitstream/10665/85376/1/9789241505895_eng.pdf?=1 Accessed on September 16, 2016
- ↑ Purcell DW, Johnson CH, Lansky A, Prejean J, Stein R, Denning P; et al. (2012). "Estimating the population size of men who have sex with men in the United States to obtain HIV and syphilis rates". Open AIDS J. 6: 98–107. doi:10.2174/1874613601206010098. PMC 3462414. PMID 23049658.
- ↑ Heffelfinger JD, Swint EB, Berman SM, Weinstock HS (2007). "Trends in primary and secondary syphilis among men who have sex with men in the United States". Am J Public Health. 97 (6): 1076–83. doi:10.2105/AJPH.2005.070417. PMC 1874206. PMID 17463387.
- ↑ Judson FN, Penley KA, Robinson ME, Smith JK (1980). "Comparative prevalence rates of sexually transmitted diseases in heterosexual and homosexual men". Am J Epidemiol. 112 (6): 836–43. PMID 6893897.
- ↑ Pandey S (2011). "Magnetic resonance imaging of the spinal cord in a man with tabes dorsalis". J Spinal Cord Med. 34 (6): 609–11. doi:10.1179/2045772311Y.0000000041. PMC 3237288. PMID 22330117.